Rationale for Integrating High-Dose Rate Intraoperative Radiation (HDR-IORT) and Postoperative External Beam Radiation with Subcutaneous Amifostine for the Management of Stage III/IV Head and Neck Cancer

Seminars in Oncology

Volumn 30, Issue 6 SUPPL. 18, 2003, Pages 40-48

  Hu, Kenneth ^a   Ship, Jonathan A ^b   Harrison, Louis B ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ACUTE TOXICITY; BEAM THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; GRANULOCYTOPENIA; HEAD AND NECK SURGERY; HEAD CANCER; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MUCOSA INFLAMMATION; NECK CANCER; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; THROMBOCYTOPENIA; XEROSTOMIA;

EID: 1642558246     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2003.11.012     Document Type: Conference Paper

References (36)

1. Stewart AK, Bland KI, McGinnis LS Jr, et al: Clinical highlights from the National Cancer Data Base, 2000. CA Cancer J Clin 50:171-183, 2000
2. Forastiere AA, Berkey B, Maor M, et al: Phase III trial to preserve the larynx: Induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone: Intergroup trial R91-11. Proc Am Soc Clin Oncol 20, 2001 (abstr 4)
3. Fu K, Pajak TF, Trotti A, et al: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16, 2000
4. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949-955, 2000
5. Calais G, Alfonsi M, Bardet E, et al: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081-2086, 1999
6. Brizel DM, Albers ME, Fisher SR, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338: 1798-1804, 1998
7. Jeremic B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000
8. Bernier J, Domenge F, Eschwege M, et al: Chemoradiotherapy as compared to radiotherapy alone significantly increases disease-free and overall survival in head and neck cancer patients after surgery: Results of EORTC phase III trial 22931. American Society of Therapeutic Radiation Oncology (ASTRO), San Francisco, CA, October 2001 (Plenary session 1)
9. Ang KK, Trotti A, Brown BW, et al: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 51:571-578, 2001
10. Peters LJ, Goepfert H, Ang KK, et al: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26:3-11, 1993
11. Amdur RJ, Parsons JT, Mendenhall WM, et al: Postoperative irradiation for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16:25-36, 1989
12. Zelefsky MJ, Harrison LB, Fass DE, et al: Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: Impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 25:17-21, 1993
13. Cooper JS, Pajak TF, Forastiere AA, et al: Patterns of failure for resected advanced head and neck cancer treated by concurrent chemotherapy and radiation therapy: An analysis of RTOG 9501/Intergroup phase III trial. American Society of Therapeutic Radiation Oncology (ASTRO), San Francisco, CA, October 2002, Plenary Session 3 (abstr)
14. Withers HR, Taylor JM, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146, 1988
15. Langendijk JA, de Jong MA, Leemans CR, et al: Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: The importance of the overall treatment time of radiotherapy. European Society for Therapeutic Radiology & Oncology (Estro) Prague, CZ, September 2002 (abstr 352)
16. Rosenthal DI, Liu L, Lee JH, et al: Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 24:115-126, 2002
17. Huang J, Barbera L, Brouwers M, et al: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 21:1424, 2003 (abstr)
18. Dale RG: The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 58:515-528, 1985
19. Garrett P, Pugh N, Ross D, et al: Intraoperative radiation therapy for advanced or recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 13:785-788, 1987
20. Toita T, Nakano M, Takizawa Y, et al: Intraoperative radiation therapy (IORT) for head and neck cancer. Int J Radiat Oncol Biol Phys 30:1219-1224, 1994
21. Freeman SB, Hamaker RC, Singer MI, et al: Intraoperative radiotherapy of head and neck cancer. Arch Otolaryngol Head Neck Surg 116:165-168, 1990
22. Rate WR, Garrett P, Hamaker R, et al: Intraoperative radiation therapy for recurrent head and neck cancer. Cancer 67:2738-2740, 1991
23. Nag S, Schuller D, Pak V, et al: Pilot study of intraoperative high dose rate brachytherapy for head and neck cancer. Radiother Oncol 41:125-130, 1996
24. Coleman CW, Roach M III, Ling SM, et al: Adjuvant electron-beam IORT in high-risk head and neck cancer patients. Front Radiat Ther Oncol 31:105-111, 1997
25. Martinez-Monge R, Azinovac I, Alcalde J, et al: IORT in the management of locally advanced or recurrent head and neck cancer. Front Radiat Ther Oncol 31:122-125, 1997
26. Spaeth J, Andreopoulos D, Unger T, et al: Intra-operative radiotherapy-5 years of experience in the palliative treatment of recurrent and advanced head and neck cancers. Oncology 54:208-213, 1997
27. Haller JR, Mountain RE, Schuller DE, et al: Mortality and morbidity with intraoperative radiotherapy for head and neck cancer. Am J Otolaryngol 17:308-310, 1996
28. Hu K, White C, Sachdeva G, et al: High-dose-rate intraoperative (HDR-IORT) radiation for head and neck cancer. American Brachytherapy Society, May 2003, New York, NY
29. Harrison LB, Zelefsky MJ, Pfister DG, et al: Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck 19:169-175, 1997
30. Bjordal K, Kaasa S, Mastekaasa A: Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28:847-856, 1994
31. Brizel DM, Wasserman TH, Henke M, et al: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339-3345, 2000
32. Henson B, Inglehart MR, Eisbruch A, et al: Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncology 37:84-93, 2001
33. Pijls M, Williams D, Braeken V, et al: Comparison of three questionnaires to quantify xerostomia in head and neck cancer patients treated by radiotherapy. Radiother Oncol 64: 523, 2002 (suppl 1) (abstr 75)
34. Cox JD, Pajak TF, Marcial VA, et al: Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group Protocol 8313. Cancer 69:2744-2748, 1992
35. Koukourakis MI, Kyrias G, Kakolyris S, et al: Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study. J Clin Oncol 18:2226-2233, 2000
36. Nag S, Schuller DE, Martinez-Monge R, et al: Intraoperative electron beam radiotherapy for previously irradiated advanced head and neck malignancies. Int J Radiat Oncol Biol Phys 42:1085-1089, 1998